Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C (Q61979046)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C |
clinical trial |
Statements
PARTNER (English)
0 references
Infliximab (Remicade®) as an Adjunct to Pegylated- Interferon α-2b and Ribavirin in the Treatment of Hepatitis C Virus Infection (English)
0 references
July 2007
0 references
May 2012
0 references
146
0 references
18 year
0 references